MET and gastric cancer: However, PI3K-AKT signaling does not seem to play a crucial role in the present context, since PI3K inhibition in gastric cancer cells had no impact on basal HER3 expression or on HER3 induction after MET inhibitor treatment (Supplementary Materials Figure S6).